GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EGEIRO Pharma (XPAR:ALVET) » Definitions » Price-to-Operating-Cash-Flow

EGEIRO Pharma (XPAR:ALVET) Price-to-Operating-Cash-Flow : (As of Jun. 04, 2025)


View and export this data going back to 2021. Start your Free Trial

What is EGEIRO Pharma Price-to-Operating-Cash-Flow?

As of today (2025-06-04), EGEIRO Pharma's share price is €0.082. EGEIRO Pharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.21. Hence, EGEIRO Pharma's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for EGEIRO Pharma's Price-to-Operating-Cash-Flow or its related term are showing as below:

XPAR:ALVET's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 24.27
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

EGEIRO Pharma's Cash Flow from Operations per share for the six months ended in Dec. 2023 was €-0.03. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.21.


EGEIRO Pharma Price-to-Operating-Cash-Flow Historical Data

The historical data trend for EGEIRO Pharma's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EGEIRO Pharma Price-to-Operating-Cash-Flow Chart

EGEIRO Pharma Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
- - - 21.55 -

EGEIRO Pharma Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only - 21.55 - - -

Competitive Comparison of EGEIRO Pharma's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, EGEIRO Pharma's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EGEIRO Pharma's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EGEIRO Pharma's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where EGEIRO Pharma's Price-to-Operating-Cash-Flow falls into.


;
;

EGEIRO Pharma Price-to-Operating-Cash-Flow Calculation

EGEIRO Pharma's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.082/-0.211
=

EGEIRO Pharma's Share Price of today is €0.082.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. EGEIRO Pharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.21.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

EGEIRO Pharma Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of EGEIRO Pharma's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


EGEIRO Pharma Business Description

Industry
Traded in Other Exchanges
N/A
Address
Avenue Jean Mermoz 32/1, Gosselies, BEL, 6041
EGEIRO Pharma is a biopharmaceutical company. The company is focused on the clinical development of drugs for Idiopathic Pulmonary Fibrosis, a chronic, devastating, and fatal disease characterized by the deterioration of lung function.

EGEIRO Pharma Headlines

No Headlines